During the meeting, the FDA asked for another clinical trial to be performed on unresectable malignant mesothelioma patients that have previously failed a different chemotherapy [...]" (2009-1-28)
mercredi 28 janvier 2009
Recent Update on Mesothelioma Treatment Oncanase
"The Alfacell Corporation recently attended a pre-NDA meeting with the United States Food and Drug Administration (FDA) to discuss the final steps needed for the New Drug Application (NDA) of Oncanase.
During the meeting, the FDA asked for another clinical trial to be performed on unresectable malignant mesothelioma patients that have previously failed a different chemotherapy [...]" (2009-1-28)
Read more...
During the meeting, the FDA asked for another clinical trial to be performed on unresectable malignant mesothelioma patients that have previously failed a different chemotherapy [...]" (2009-1-28)
